510(k) K243243
K243243 is an FDA 510(k) premarket notification submitted by Quantalx Neuroscience, Ltd. for the device "Delphi MCS Electrode Cap". The FDA issued a decision of Substantially Equivalent on February 6, 2025. The device falls under product code GXY (Electrode, Cutaneous), a Class II device regulated under 21 CFR 882.1320. Quantalx Neuroscience, Ltd. has at least 2 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 6, 2025
- Date Received
- October 11, 2024
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Electrode, Cutaneous
- Device Class
- Class II
- Regulation Number
- 882.1320
- Review Panel
- NE
- Submission Type